As millions turn to GLP-1 medications like Ozempic and Mounjaro in pursuit of metabolic health, a large observational study from the University of Pennsylvania now surfaces an unexpected companion to these drugs' celebrated effects: a meaningfully elevated risk of hair loss. The finding does not overturn the calculus of treatment, but it deepens it — reminding us that every intervention in the body's intricate economy carries costs that may not appear on the label. The hair follicles, it seems, bear quiet witness to the speed of transformation.
GLP-1 Diabetes Drugs Linked to Increased Hair Loss Risk
Hair loss affects quality of life and self-image for patients using these increasingly popular weight-loss and diabetes medications.